Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
190.00    9.00 (4.74%)
Bid:
185.00
Ask:
195.00
Spread: 10.00 (5.405%)
Market Cap: £105.12m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Update

24 Apr 2025 07:00

RNS Number : 9461F
Somero Enterprises Inc.
24 April 2025
 

24 April 2025

Somero Enterprises, Inc.

("Somero" or "the Company")

 

Trading Update

 

Somero® provides the following update on trading for the three months ended 31 March 2025 and on expectations for FY 2025 results.

 

Market conditions and Q1 2025 trading

 

Non-residential construction in the US, the Company's largest market, remains active, supported by demand from end markets including manufacturing, warehousing and logistics, data centers, chip factories, and electric vehicle and battery plants. However, recent developments in international trade relations and US immigration policies have heightened global uncertainty. This has exacerbated an already challenging selling environment in the US, where elevated interest rates remain the primary factor causing project delays and pauses, alongside broader macroeconomic pressures.

 

While customers continue to report robust bidding levels and healthy project backlogs, economic uncertainty and a lack of clarity around the timing of project starts or resumptions are impacting capital investment decisions. As a result, trading in Q1 was weaker than expected.

 

Cost actions

 

In response to the softer trading environment and consistent with Somero's agile operating model, the Company has initiated a targeted operational workforce reduction of approximately 15%. This restructuring, effective immediately, is limited to areas directly affected by lower sales volumes and does not currently impact customer-facing teams, future growth functions or administrative support. Together with a reduction in variable expenses and tighter cost controls, these actions are expected to partly offset the profitability impact of lower revenues in 2025. Management will continue to monitor commercial activities and will reassess its cost structure as required.

 

Updated FY 2025 guidance

 

In light of these market dynamics, and assuming trading conditions remain the same through 2025, Somero now expects:

 

·

Revenues of approximately US$ 105.0m (previous market consensus estimate: US$ 113.6m)

·

EBITDA of approximately US$ 24.0m (previous market consensus estimate: US$ 28.6m)

·

Year-end cash of approximately US$ 28.0m (previous market consensus estimate: US$ 31.2m)

 

Tim Averkamp, CEO of Somero, said:

 

"Somero has successfully navigated challenging market conditions many times before, and we are taking measured, proactive steps to do so again. Our flexible operating model allows us to respond decisively to near-term uncertainty while continuing to invest in product innovation and other strategic initiatives that underpin future growth.

 

"The fundamental demand drivers in our core markets remain intact, and we believe the actions we are taking now will position us to emerge stronger as conditions improve. Supported by a strong balance sheet, we remain focused on executing our growth strategy and are confident in Somero's long-term prospects."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this Announcement, this inside information is now considered to be in the public domain.

 

For further information, please contact:

 

Somero Enterprises, Inc.

 www.somero.com

Tim Averkamp, CEO

+1 239 210 6500

Vincenzo LiCausi, CFO

Howard Hohmann, EVP Sales

 

Cavendish Capital Markets Ltd (NOMAD and Broker)

+44 (0)20 7220 0500

Matt Goode/Seamus Fricker/Trisyia Jamaludin (Corporate Finance)

 

Tim Redfern/Harriet Ward (Corporate Broking)

 

 

 

Alma (Financial Communications Advisor)

somero@almastrategic.com 

David Ison

+44 (0)20 3405 0205

Rebecca Sanders-Hewett

 

Will Merison

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKNBBKBKBNQB
Date   Source Headline
1st May 20257:00 amRNSAnnual Report and Notice of AGM
30th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Apr 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20257:00 amRNSTrading Update
22nd Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20257:00 amRNSAppointment of New Chairman
11th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Apr 20254:35 pmRNSHolding(s) in Company
1st Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Mar 20257:00 amRNSAppointment of New CEO
20th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20257:00 amRNSRSUs & Director/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Mar 20257:00 amRNSFinal Results
7th Mar 20252:35 pmRNSHolding(s) in Company
6th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Feb 20257:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Feb 20257:00 amRNSNotice of Investor Presentation
3rd Feb 20256:10 pmRNSHolding(s) in Company
30th Jan 20257:00 amRNSTrading Update
20th Dec 20247:00 amRNSDirectorate Changes
17th Dec 20245:04 pmRNSHolding(s) in Company
5th Dec 20245:02 pmRNSHolding(s) in Company
5th Dec 20244:41 pmRNSHolding(s) in Company
4th Dec 20244:29 pmRNSHolding(s) in Company
26th Nov 20244:47 pmRNSHolding(s) in Company
21st Nov 20249:41 amRNSHolding(s) in Company
19th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Aug 20247:00 amRNSInterim Results
20th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Aug 20247:00 amRNSNotice of Investor Presentation
31st Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20247:00 amRNSTrading Update
26th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.